Here are the S-1 registration statements from Beneficient (BENF) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-1 covers the registration statement a company files to sell shares publicly, so if you follow BENF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BENF filings page.
Beneficient is registering the resale of up to 55,671,296 shares of Class A common stock for the benefit of various selling holders. The shares include stock issuable to Yorkville under a $100.0 million amended standby equity purchase agreement, conversions of multiple Series B preferred stock series, commitment fee shares and Yorkville Warrant Shares.
The company will not receive proceeds from selling holders’ resales, but may receive cash when it sells stock to Yorkville, when Yorkville exercises $21.04 Yorkville Warrants, and from $4.0 million of Promissory Notes, which it plans to use for working capital, liquidity transactions and potential related-party payments. The A&R SEPA is priced at 96–97% of Nasdaq VWAP, is subject to a 4.99% beneficial ownership cap and a 19.99% Nasdaq exchange cap, and is supported by subsidiary guarantees. Beneficient operates a technology-enabled platform providing liquidity, custody and related services for alternative assets through regulated trust and broker-dealer subsidiaries, while highlighting substantial risks including going-concern uncertainty, events of default under credit agreements, multiple legal proceedings and the potential for significant dilution from future share issuances.
Beneficient has filed an S-1 registration statement covering the resale of up to 71,017,840 shares of Class A common stock by existing investors and other selling holders. The largest component is 64,371,217 SEPA Shares that may be issued to Yorkville under a $250 million Standby Equity Purchase Agreement, alongside warrant shares, conversion shares from multiple Series B preferred stocks, and previously issued vendor and settlement shares. The company will not receive proceeds from resale of these shares, although it may receive cash if it elects to issue stock to Yorkville or if Yorkville exercises warrants for cash.
The filing details prior reverse stock splits in 2024 and 2025, a large increase and subsequent reduction in authorized shares, and SEPA pricing formulas based on Nasdaq VWAP. At a reference price of $6.85, SEPA issuances could reach roughly 73% of current outstanding Class A shares, highlighting significant potential overhang. Extensive risk factors are emphasized, including Nasdaq listing deficiencies, events of default under a loan agreement, ongoing and potential litigation (including with the founder and former CEO), prior SEC investigation, going concern doubts, and the company’s status as a controlled company with Class B holders electing a majority of directors.